• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT ANTI-HBS Back to Search Results
Catalog Number 07C18-29
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/01/2018
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There is no further patient information provided by the customer.This report is being filed on an international product, list number 7c18 that has a similar product distributed in the us, list number 1l82.
 
Event Description
The customer reported false (b)(6) architect (b)(6) results on one patient.The results provided were: (b)(6) 2017 =(b)(6) / (b)(6) 2018 = (b)(6) / (b)(6) 2019 = (b)(6).The patient has not been vaccinated.There was no reported impact to patient management.
 
Manufacturer Narrative
A review of tickets determined normal complaint activity for lot 01347fn00 and no trends were identified for the issue for the product.Return testing was not completed as returns were not available.Historical performance of reagent lot 01347fn00 was evaluated using world wide data from abbottlink.The median population result for the lot is comparable with all other lots in the field and within established baselines and confirms no systemic issue for the lot.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.The overall sensitivity of the architect anti-hbs assay was estimated to be 95.97% at the lower 95% confidence level.Therefore, false elevated and false depressed results may occur.Based on the investigation no product deficiency was identified for the architect anti-hbs reagent, lot 01347fn00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT ANTI-HBS
Type of Device
ANTI-HBS
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key9667187
MDR Text Key205520584
Report Number3008344661-2020-00010
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 03/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2020
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/14/2020
Device Catalogue Number07C18-29
Device Lot Number01347FN00
Was Device Available for Evaluation? No
Date Manufacturer Received03/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I1000SR ANALYZER, LN 01L86-01,; ARCHITECT I1000SR ANALYZER, LN 01L86-01,; SERIAL # (B)(4); SERIAL # (B)(4)
-
-